cbdMD, Inc.
YCBD· NYSE
Filed May 15, 2018 · 10-Q · 45 days after period end · 0001654954-18-005463
| Metric | Q2 2018 | Q2 2017 |
|---|---|---|
| Revenue | $3.08M | $1.41M |
| Net Income | $1.64M | -$288.20K |
| EPS Diluted | $0.17 | -$0.13 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
cbdMD, Inc. · CIK 1644903 · Engraved from SEC EDGAR
ended Mar 31, 2018 · filed May 15, 2018 · 45 d after period end